Arcus Biosciences financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

아쿠스 바이오사이언시스NYSE:RCUS · New York Stock Exchange · Healthcare · sector #13

$24.74+1.23%

2026-10-05 close

Arcus Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $258M. 2024 operating profit was −$330M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy